Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)

Market Cap	14.12B -45.7%
Revenue (ttm)	1.01B -18.6%
Net Income	11.30M -80.3%
EPS	0.01 -78.7%
Shares Out	966.49M
PE Ratio	1,126.71
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,231,500
Open	14.16
Previous Close	14.77
Day's Range	14.16 - 14.79
52-Week Range	13.52 - 30.20
Beta	0.59
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 27, 2026

About SHE:000766

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. The company provides anti-tumor drugs, gynecological medications, medication for rheumatic bone pain, urological medications, heat-clearing and detoxifying drugs, cardiovascular and cerebrovascular drugs, digestive medications, tonifying and restorative medicines, respiratory medication, diabetes medication, ENT medication, and pediatric medications. It also offers...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 1,480
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000766

Financial Performance

In 2025, SHE:000766's revenue was 1.17 billion, a decrease of -11.54% compared to the previous year's 1.32 billion. Earnings were 34.29 million, a decrease of -39.25%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 6, 2026

Data Sources Report a data error